Akemi Suzuki Selected Research

Neoplasms (Cancer)

1/2019	Globo-series glycosphingolipids enhance Toll-like receptor 4-mediated inflammation and play a pathophysiological role in diabetic nephropathy.
1/2019	Overexpression of HexCer and LacCer containing 2-hydroxylated fatty acids in cholangiocarcinoma and the association of the increase of LacCer (d18:1-h23:0) with shorter survival of the patients.
5/2012	Colonic epithelial cells express specific ligands for mucosal macrophage immunosuppressive receptors siglec-7 and -9.
3/2009	Ganglioside GM3 inhibits VEGF/VEGFR-2-mediated angiogenesis: direct interaction of GM3 with VEGFR-2.
3/2006	Hypoxic culture induces expression of sialin, a sialic acid transporter, and cancer-associated gangliosides containing non-human sialic acid on human cancer cells.
7/2004	Loss of disialyl Lewis(a), the ligand for lymphocyte inhibitory receptor sialic acid-binding immunoglobulin-like lectin-7 (Siglec-7) associated with increased sialyl Lewis(a) expression on human colon cancers.
5/2004	Hypoxia induces adhesion molecules on cancer cells: A missing link between Warburg effect and induction of selectin-ligand carbohydrates.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Akemi Suzuki Research Topics

Disease

7	Neoplasms (Cancer) 01/2019 - 05/2004
3	Infections 01/2020 - 12/2009
3	Inflammation (Inflammations) 01/2019 - 09/2013
3	Alzheimer Disease (Alzheimer's Disease) 01/2018 - 05/2014
3	Immune System Diseases (Immune Disorders) 01/2018 - 02/2012
3	Dengue (Dengue Fever) 01/2016 - 09/2005
2	Congenital Abnormalities (Deformity) 10/2021 - 03/2020
2	Rheumatoid Arthritis 10/2021 - 01/2020
2	Insulin Resistance 01/2018 - 01/2015
2	Asthma (Bronchial Asthma) 01/2018 - 02/2012
2	Proteinuria 09/2011 - 11/2006
2	Hypoxia (Hypoxemia) 03/2006 - 05/2004
2	Colonic Neoplasms (Colon Cancer) 07/2004 - 05/2004
2	Neoplasm Metastasis (Metastasis) 07/2004 - 05/2004
1	Hallux Valgus 10/2021
1	Patellar Dislocation 03/2020
1	Obesity 01/2020
1	Infectious Arthritis (Septic Arthritis) 01/2020
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2019
1	Carcinoma (Carcinomatosis) 01/2019
1	Cholangiocarcinoma 01/2019
1	Endometrial Neoplasms (Endometrial Cancer) 01/2019
1	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 01/2018
1	Type 2 Diabetes Mellitus (MODY) 01/2018
1	Microcephaly 04/2016
1	Renal Cell Carcinoma (Grawitz Tumor) 04/2016
1	Zika Virus Infection 01/2016
1	Cardiovascular Diseases (Cardiovascular Disease) 11/2015
1	Blister (Bulla) 05/2015
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2015
1	Metabolic Diseases (Metabolic Disease) 01/2015
1	Hyperglycemia 12/2014
1	Glucose Intolerance 01/2013
1	Carcinogenesis 05/2012
1	Polyuria 02/2012
1	Oliguria 02/2012
1	Urologic Diseases (Urinary Tract Disease) 09/2011
1	Leukemia 12/2010
1	Hantavirus Infections 08/2009
1	Arthritis (Polyarthritis) 03/2009
1	Diabetic Retinopathy (Retinopathy, Diabetic) 03/2009

Drug/Important Bio-Agent (IBA)

6	GangliosidesIBA 01/2018 - 03/2006
3	G(M3) GangliosideIBA 01/2020 - 09/2013
3	Polysaccharides (Glycans)IBA 01/2019 - 04/2005
3	GlycosphingolipidsIBA 01/2019 - 04/2016
3	CA-19-9 Antigen (CA 19-9 Antigen)IBA 05/2012 - 05/2004
3	LigandsIBA 05/2012 - 05/2004
3	AntigensIBA 11/2011 - 08/2009
2	SphingolipidsIBA 01/2019 - 01/2012
2	Amyloid (Amyloid Fibrils)IBA 01/2018 - 01/2015
2	Proteins (Proteins, Gene)FDA Link 01/2018 - 02/2007
2	Monoclonal AntibodiesIBA 04/2016 - 09/2005
2	EnzymesIBA 01/2016 - 03/2006
2	AntibodiesIBA 01/2016 - 08/2008
2	Sialyl Lewis X AntigenIBA 05/2012 - 05/2004
2	Glycoproteins (Glycoprotein)IBA 09/2011 - 04/2005
2	DNA (Deoxyribonucleic Acid)IBA 08/2006 - 05/2004
2	N-Acetylneuraminic Acid (Sialic Acid)IBA 03/2006 - 07/2004
2	SialyltransferasesIBA 07/2004 - 05/2004
2	E-SelectinIBA 07/2004 - 05/2004
1	alpha-DefensinsIBA 01/2020
1	Calcium PyrophosphateIBA 01/2020
1	CoagulaseIBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	HMMC-1 monoclonal antibodyIBA 01/2019
1	H antigenIBA 01/2019
1	GlycolipidsIBA 01/2019
1	Blood Group Antigens (Blood Groups)IBA 01/2019
1	globotetraosylceramideIBA 01/2019
1	OligosaccharidesIBA 01/2019
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2019
1	globotriaosylceramide (globotriosylceramide)IBA 01/2019
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2019
1	GlycosyltransferasesIBA 01/2019
1	LeptinIBA 01/2018
1	Insulin ReceptorIBA 01/2018
1	Amino Acids FDA Link 04/2016
1	UDP-galactose-lactosylceramide alpha 1-4-galactosyltransferaseIBA 04/2016
1	Immunoglobulin M (IgM)IBA 01/2016
1	ImmunosorbentsIBA 01/2016
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 11/2015
1	TubulinIBA 05/2015
1	oxidized low density lipoproteinIBA 01/2015
1	Linseed Oil (Flaxseed Oil)IBA 12/2014
1	Apolipoproteins E (ApoE)IBA 05/2014
1	OvalbuminIBA 09/2013
1	phytosphingosineIBA 01/2013
1	Sialic Acid Binding Immunoglobulin-like LectinsIBA 05/2012
1	haematoside synthetaseIBA 02/2012
1	Serum AlbuminIBA 02/2012
1	Indicators and Reagents (Reagents)IBA 09/2011
1	lentil lectinIBA 09/2011
1	LectinsIBA 09/2011
1	EpitopesIBA 12/2010
1	enhanced green fluorescent proteinIBA 12/2009

Therapy/Procedure

1	Arthroplasty 10/2021
1	Osteotomy 03/2020
1	Platelet Transfusion (Blood Platelet Transfusions) 01/2016
1	Oral Administration 01/2013
1	Subcutaneous Injections 03/2009